Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7675880 | 0.84 | TP53 (0.54) | TP53CES2NPSR1POLBRAB9A | |
| SCHEMBL2736852 | 0.84 | ALDH1A1 (0.50) | TP53CES2NPSR1POLBLMNA | |
| SCHEMBL17681668 | 0.82 | CES2 (0.49) | TP53CES2NPSR1POLBRAB9A | |
| SCHEMBL10067058 | 0.81 | ALDH1A1 (0.59) | TP53POLBRAB9AMEN1KMT2A | |
| SCHEMBL11304484 | 0.81 | TP53 (0.47) | TP53CES2NPSR1POLBRAB9A | |
| SCHEMBL11821275 | 0.80 | EPHX2 (0.43) | CES2RAB9AMAPTALDH1A1KDM4E | |
| SCHEMBL11876112 | 0.79 | TP53 (0.45) | TP53CES2POLBMEN1KMT2A | |
| SCHEMBL5133571 | 0.78 | HDAC1 (0.47) | TP53CES2POLBMEN1KMT2A | |
| SCHEMBL11833450 | 0.77 | SMN1; SMN2 (0.47) | TP53NPSR1POLBMAPTHTT | |
| SCHEMBL9819254 | 0.77 | RXRA (0.44) | TP53RAB9AMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9677053-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2017-06-13 | — | — | US | disclosed |
| US-9677053-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2017-06-13 | — | — | US | disclosed |
| US-9677053-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2017-06-13 | — | — | US | disclosed |
| US-20160237411-A1 | LACCASES FOR BIO-BLEACHING | VERENIUM CORPORATION | 2016-08-18 | — | — | US | disclosed |
| US-20160237411-A1 | LACCASES FOR BIO-BLEACHING | VERENIUM CORPORATION | 2016-08-18 | — | — | US | disclosed |
| US-20160237411-A1 | LACCASES FOR BIO-BLEACHING | VERENIUM CORPORATION | 2016-08-18 | — | — | US | disclosed |
| US-9353477-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2016-05-31 | — | — | US | disclosed |
| US-9353477-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2016-05-31 | — | — | US | disclosed |
| US-9353477-B2 | Laccases for bio-bleaching | BASF ENZYMES LLC (US) | 2016-05-31 | — | — | US | disclosed |
| EP-2434008-B1 | Laccases for pulp bio-bleaching | BASF ENZYMES LLC (US) | 2015-07-08 | — | — | EP | disclosed |
| EP-2059587-B1 | LACCASES FOR PULP BIO-BLEACHING | VERENIUM CORP (US) | 2012-01-04 | — | — | EP | disclosed |
| US-20100018658-A1 | Laccases for Bio-Bleaching | VERENIUM CORPORATION (US) | 2010-01-28 | — | — | US | disclosed |
| US-20100018658-A1 | Laccases for Bio-Bleaching | VERENIUM CORPORATION (US) | 2010-01-28 | — | — | US | disclosed |
| US-20100018658-A1 | Laccases for Bio-Bleaching | VERENIUM CORPORATION (US) | 2010-01-28 | — | — | US | disclosed |
| EP-2059587-A2 | LACCASES FOR PULP BIO-BLEACHING | Verenium Corporation (US) | 2009-05-20 | — | — | EP | disclosed |
| WO-2008027501-A2 | LACCASES FOR PULP BIO-BLEACHING | VERENIUM CORPORATION (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027501-A2 | LACCASES FOR PULP BIO-BLEACHING | VERENIUM CORPORATION (US) | 2008-03-06 | — | — | WO | disclosed |
| US-4190431-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1980-02-26 | — | — | US | disclosed |
| US-4182872-A | CORRESPONDING 4-CARBOBENZOXY COMPOUNDS, 2,3,4,4A-TETRAHYDRO-1H-PYRAZINO(1,2-A)QUINOXALIN-5(6H)-ONES, 2,3,4,4A,5,6-HEXAHYDRO-1H-PYRAZINO(1,2-A)QUINOXALINES, HYPOTENSIVE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-01-08 | — | — | US | disclosed |
| US-4089958-A | HYPOTENSIVE AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100018658-A1 | Laccases for Bio-Bleaching | AOX1, GUSB, LPO | TP53 3869/4885CES2 123/4885NPSR1 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.